Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2007
10/04/2007WO2007045982A3 Use of collagen in combination with oxygen- and ozonereleasing perfluorocarbons for the preparation of a medicament for the treatment of skin lesions
10/04/2007WO2007045389A3 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
10/04/2007WO2007044362A3 Allele-specific rna interference
10/04/2007WO2007041689A3 Methods of site-specific labeling of molecules and molecules produced thereby
10/04/2007WO2007037790A3 Modified release famciclovir compositions
10/04/2007WO2007034321A3 Wound-healing pharmaceutical compositions comprising at least one soluble dextran and at least one platelet-derived growth factor
10/04/2007WO2007034320A3 Pdgf amphiphilic polymer complex
10/04/2007WO2007032887A3 Thio-containing inhibitors of aminopeptidase p, compositions thereof and method of use
10/04/2007WO2007026246A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007015170A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007014156A3 Fibroblast growth factor-2 promotes neurogenesis and neuroprotection and prolongs survival in huntington's disease
10/04/2007WO2007002465A3 Stabilizing alkylglycoside compositions and methods thereof
10/04/2007WO2006138099A3 Bone morphogenetic protein formulations
10/04/2007WO2006122825A3 Single domain vhh antibodies against von willebrand factor
10/04/2007WO2006116156A3 Toxin peptides with extended blood halflife
10/04/2007WO2006071949A3 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
10/04/2007WO2005079523A3 Novel teleost derived antimicrobal polypeptides
10/04/2007WO2005072277A3 Amidated parathyroid hormone fragments and uses thereof
10/04/2007WO2005046575A3 Amino acid prodrugs
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007WO2005030133A3 Treatment with agonists of toll-like receptors
10/04/2007WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies
10/04/2007WO2004069193A3 Methods and compositions for inhibiting cholesterol uptake
10/04/2007WO2004043361A3 Compositions and methods for the treatment of natural killer cell related diseases
10/04/2007WO2004041115A3 Novel human elastases and stress urinary incontinence
10/04/2007WO2002059258A3 Chimeric proteins for prevention and treatment of hiv infection
10/04/2007US20070232792 Method for the Production of Recombinant Peptides with a Low Amount of Trisulfides
10/04/2007US20070232789 Factor viii compositions and methods
10/04/2007US20070232788 Factor viii compositions and methods
10/04/2007US20070232692 Method of Treating Cancer Using Dithiocarbamate Derivatives
10/04/2007US20070232568 Carbohydrate Composition and Its Use for the Preparation of a Medicament for Treating or Preventing Pulmonary Inflammation or Acute Respiration Distress Syndrome
10/04/2007US20070232560 Treatment of skin with adenosine or adenosine analog
10/04/2007US20070232558 Methods and compositions for treating prostate cancer using dna vaccines directed to cancer testis antigen
10/04/2007US20070232557 Methods and compositions for inhibiting the function of polynucleotide sequences
10/04/2007US20070232556 Methods and compositions for the treatment of neurological diseases and disorders
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232550 Use of Hamlet (Human Alpha-Lactalbumin Made Lethal to Tumour Cells) for Treating Viral Infections
10/04/2007US20070232549 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/04/2007US20070232548 Enhancement of Endogenous Gonadotropin Production
10/04/2007US20070232547 Two synthetic peptides for treatment and prevention of cancers
10/04/2007US20070232546 Linear Natriuretic Peptide Constructs
10/04/2007US20070232545 cholesterol ester hydrolase enhancing domain of mammalian serum amyloid A protein; mimetics; for treatment of atherosclerosis, cardiovascular disease or coronary heart disease; bioavailability
10/04/2007US20070232544 Ribonucleases and methods of making them recombinantly
10/04/2007US20070232543 Ribonucleases and methods of making them recombinantly
10/04/2007US20070232542 Methods for Modifying Cell Motility Using Factor VIIa Antagonist
10/04/2007US20070232541 Methods of regulating angiogenisis through stabilization of pedf
10/04/2007US20070232540 Treatment of ischemia
10/04/2007US20070232539 Lipid therapy
10/04/2007US20070232538 Uses of polypeptides
10/04/2007US20070232537 Intranasal pyy formulations with improved transmucosal pharmacokinetics
10/04/2007US20070232536 Pharmaceutical compositions containing plasma protein
10/04/2007US20070232534 Promote the growth of neurons, which is revealed by the increase in the thickness, length and number of branches in the neurites; stimulating the proliferation of neuron stem cells using propolin
10/04/2007US20070232533 Use of Vinca Alkaloids and Salts Thereof
10/04/2007US20070232532 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
10/04/2007US20070232531 Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
10/04/2007US20070232530 treating a mammal with hepatitis C; non-immunosuppressive
10/04/2007US20070232529 Active agent delivery systems and methods for protecting and administering active agents
10/04/2007US20070232528 Formulation comprising histone deacetylase inhibitors
10/04/2007US20070232527 Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
10/04/2007US20070232526 Bovine osteopontin formulations for the improvement of the wound healing process
10/04/2007US20070232525 Method of treating pancreatitis
10/04/2007US20070232524 Use of N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability
10/04/2007US20070232523 Mixture with a cyclic 3', 5'-adenylic acid modulator such as forskolin, activators of adenylate cyclase or macrophages, macrophage-derived factors that stimulate cAMP, calcium ionophores, inhibitors of phosphodiesterase or beta-2-adrenoreceptor or vasoactive intestinal peptide; optional axogenic factor
10/04/2007US20070232522 For modulating immune activity, hepatitis infections, the extent of nephritis, and the growth of a cancer
10/04/2007US20070232521 that can trap isotopic fluorine so that when the biological molecule accumulates in the desired type of cell, the isotopic fluorine is imaged by PET scan
10/04/2007US20070232520 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
10/04/2007US20070231896 Use of Il-17-for Maturation of Oocytes
10/04/2007US20070231863 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
10/04/2007US20070231862 Peptide scaffolds for transfer of molecules into eukaryotic cells
10/04/2007US20070231859 Novel scavenger receptor
10/04/2007US20070231842 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231814 DNA sequences isolated from human colonic epithelial cells
10/04/2007US20070231792 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
10/04/2007US20070231407 Method of treating gallium-nitrate resistant tumors using gallium-containing compounds
10/04/2007US20070231404 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
10/04/2007US20070231372 Tissue Sealant
10/04/2007US20070231366 Superabsorbent, freeze dried hydrogels for medical applications
10/04/2007US20070231363 Coatings formed from stimulus-sensitive material
10/04/2007US20070231359 Methods and compositions for piercing studs with bioactive polymer coating
10/04/2007US20070231340 formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children; provides coverage for serotypes 6A and 19A; periodic acid oxidation of the polysaccharide in the presence of bivalent cations
10/04/2007US20070231339 Fungal immunostimulatory compositions
10/04/2007US20070231332 Inhibition of Cancer Metastasis
10/04/2007US20070231330 Method for the improvement of neuronal regeneration
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007US20070231317 S100 Protein Inhibitors for Treating Leukemia
10/04/2007US20070231316 Treatment of Cognitive Dysfunction in Lupus
10/04/2007US20070231315 Stabilized preparations of serine endopeptidases, their preparation and use
10/04/2007US20070231314 Polypeptides and compositions derived from the horny layer of the epidermis and its use
10/04/2007US20070231313 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
10/04/2007US20070231312 Nutritional supplement for pregnant females
10/04/2007US20070231308 Pharmacokinetics; chemical stability; gene therapy
10/04/2007US20070231307 Energy assisted stem cell extract
10/04/2007US20070231301 Parenteral low dose type 1 interferons for bladder cancer
10/04/2007US20070231300 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
10/04/2007US20070231299 Immunostimulant; antibodies used to measure efficacy; dendritic and antigen presenting cells; lung and renal cancer
10/04/2007US20070231298 Cytokine-expressing cancer immunotherapy combinations
10/04/2007US20070231284 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb
10/04/2007US20070231275 Method for regenerating tooth germ
10/04/2007US20070231264 Mammalian cytokine; related reagents
1 ... 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 ... 3163